BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Why is the WHO delaying an EUL status to Covaxin?

The World Health Organisation usually takes around 6 to 9 weeks to analyse the data submitted by a vaccine manufacturer and then takes a call on whether to...

October 30, 2021 | Opinion | By "Akhil Pathak , an independent writer who keeps an eye on issues related to health, education, society, global politics and defence. He also follows the geo-strategic matters that are directly or indirectly related to the security framework of India."

How Covid-19 Became a Catalyst for Tracking Health Data and Digitizing Healthcare

Ever since we began living in organized societies, we have attempted to find better ways to manage our health. As a result, we’ve often appointed a f...

October 15, 2021 | Opinion

In Asia, and across the globe, the medical device and diagnostic market was boosted by the pandemic and some quick solutions were developed.

What strategic changes have you brought about within the business due to COVID-19? Bloom Diagnostics decided to make healthcare more acces...

October 11, 2021 | Opinion

Strengthen mental health services: WHO

“Majority of the people living with mental health problems in the low-and middle-income countries do not get adequate treatment. The ongoing COVID-19...

October 10, 2021 | News

We continue to see expansion across each of our key Optimer application areas, therapeutics, bioprocessing, diagnostics, and research reagents

What strategic changes have you brought about within the business due to COVID-19? The COVID-19 pandemic highlighted a number of issues within the l...

October 06, 2021 | Opinion

We expect more first-in-class and biosimilar drugs to be approved and produced in China

Francis Van Parys is currently responsible for providing transformational technologies in biopharmaceutical research, manufacturing and diagnostics to Cyti...

October 04, 2021 | Influencers

Oliver Healthcare Packaging to play an important role in patient safety and provide customers with the best material designs, a broad selection of products, and good technical support when launching their devices in the market.

What strategic changes have you brought about within the business due to COVID-19? Oliver Healthcare Packaging (Oliver) focuses on the...

October 01, 2021 | Influencers

Why is the WHO delaying an EUL status to Covaxin?

How Covid-19 Became a Catalyst for Tracking Health Data and Digitizing Healthcare

In Asia, and across the globe, the medical device and diagnostic market was boosted by the pandemic and some quick solutions were developed.

Strengthen mental health services: WHO

We continue to see expansion across each of our key Optimer application areas, therapeutics, bioprocessing, diagnostics, and research reagents

We expect more first-in-class and biosimilar drugs to be approved and produced in China

Oliver Healthcare Packaging to play an important role in patient safety and provide customers with the best material designs, a broad selection of products, and good technical support when launching their devices in the market.

Leadership Changes at Merck Group Level to Further Support Accelerated Growth

What Is the Burden of Disease?

Agilent Announces Thought Leader Award to David R. Liu at the Broad Institute

Discovery Technologies: The Story of Remdesivir

How Pfizer boosted security levels across its global manufacturing facilities

Staying flexible in biomanufacturing with optionality

Seizing the opportunities from disruptive forces in biopharma

Stay Connected